Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Lucas T, Schulz"'
Autor:
Noora Reffat, Rebecca J. Schwei, Meggie Griffin, Aurora Pop-Vicas, Lucas T. Schulz, Michael S. Pulia
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 38, Iss , Pp 49-65 (2024)
Objectives: The COVID-19 pandemic disrupted antimicrobial stewardship and infection prevention operations worldwide, raising concerns for an acceleration of antimicrobial resistance (AMR). Therefore, we aimed to define the scope of peer reviewed rese
Externí odkaz:
https://doaj.org/article/ffab22f3bad7465ba45ba5c42a4cf370
Autor:
Laurel Legenza, Kyle McNair, Song Gao, James P. Lacy, Brooke J. Olson, Thomas R. Fritsche, Lucas T. Schulz, Samantha LaMuro, Frances Spray-Larson, Tahmeena Siddiqui, Warren E. Rose
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract The global threat of antimicrobial resistance (AMR) varies regionally. This study explores whether geospatial analysis and data visualization methods detect both clinically and statistically significant variations in antibiotic susceptibilit
Externí odkaz:
https://doaj.org/article/ee0fd78550b1453cb8c4db6a5b1ff35e
Publikováno v:
EMJ Microbiology & Infectious Diseases (2022)
For decades, infectious disease and public health experts have recognised antimicrobial resistance (AMR) and resulting infections due to multidrug resistant organisms as a persistent and increasingly urgent threat to public health at the local, natio
Externí odkaz:
https://doaj.org/article/5bcfe329298042f094c9f1c46168af69
Autor:
Thomas J. Dilworth, PharmD, Lucas T. Schulz, PharmD, Scott T. Micek, PharmD, Marin H. Kollef, MD, Warren E. Rose, PharmD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 7, p e0726 (2022)
OBJECTIVE:. β-lactams are the cornerstone of empiric and targeted antibiotic therapy for critically ill patients. Recently, there have been calls to use β-lactam therapeutic drug monitoring (TDM) within 24–48 hours after the initiation of therapy
Externí odkaz:
https://doaj.org/article/dbec365f4e5b4cd384caeda2d220cd69
Autor:
Lauren E. Brownell, Meagan L. Adamsick, Erin K. McCreary, Joshua P. Vanderloo, Erika J. Ernst, Emily R. Jackson, Lucas T Schulz
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss S1, Pp 13-19 (2020)
Abstract Background Vancomycin treatment of complicated Gram-positive infections is associated with laboratory monitoring, nephrotoxicity, and multiple daily dosing. Oritavancin, a lipoglycopeptide antibiotic with a once-weekly dosing strategy and si
Externí odkaz:
https://doaj.org/article/ff140c0e9c5d480b8abdd1763d038ed1
Autor:
Megan R. Wimmer, Lucas T. Schulz, Ashlee G. Hamel, Rebecca J. Schwei, Karen Fong, Donna R. Burgess, Meghan Brett, Cory M. Hale, Marisa Holubar, Rupali Jain, Rachel Larry, Emily S. Spivak, Helen Newland, Jessica Njoku, Michael Postelnick, Carla Walraven, Michael S. Pulia
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: The coronavirus disease 2019 (COVID-19) pandemic has required healthcare systems and hospitals to rapidly modify standard practice, including antimicrobial stewardship services. Our study examines the impact of COVID-19 on the an
Externí odkaz:
https://doaj.org/article/5f93de46788e4766a0a0869d8825d8b4
Autor:
Michael S. Pulia, Ian Wolf, Lucas T. Schulz, Aurora Pop-Vicas, Rebecca J. Schwei, Peter K. Lindenauer
Publikováno v:
Western Journal of Emergency Medicine, Vol 21, Iss 5 (2020)
While current research efforts focus primarily on identifying patient level interventions that mitigate the direct impact of COVID-19, it is important to consider the collateral effects of COVID-19 on antimicrobial resistance. Early reports suggest h
Externí odkaz:
https://doaj.org/article/4b3dad49c3764f348612c41d42c67203
Autor:
Anna M. Kane, Erica M. Keenan, Kasheng Lee, Katherine J. Hartkopf, Trisha A. Ludwig, Philip J. Trapskin, Joshua P. Vanderloo, Lucas T Schulz
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:29-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfe4347f33b8b877c3e5734af3a7f5c7
https://doi.org/10.1002/jac5.1729
https://doi.org/10.1002/jac5.1729
Autor:
Margaret R, Jorgenson, Jillian L, Descourouez, Lucas T, Schulz, Christopher M, Saddler, Jeannina A, Smith
Publikováno v:
Current Opinion in Organ Transplantation. 28:8-14
Despite the availability of potent antivirals, consensus guidelines and decades of research, cytomegalovirus (CMV) continues to be associated with negative outcomes after solid organ transplant. This has been attributed to postprophylaxis CMV infecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f25a6eac5a9d241b25af484e3a258a
https://doi.org/10.1097/mot.0000000000001032
https://doi.org/10.1097/mot.0000000000001032
Autor:
Hanna L. Kleiboeker, Jillian L. Descourouez, Lucas T. Schulz, Didier A. Mandelbrot, Jon S. Odorico, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, Margaret R. Jorgenson
Publikováno v:
Annals of Pharmacotherapy. 57:597-608
Objective: To review the efficacy and safety of maribavir for management of cytomegalovirus (CMV) in solid organ transplant recipients. Data Sources: A literature search of PubMed and the Cochrane Controlled Trials Register (1960 to early July 2022)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c200ad3c0be0697c5a63099faa4881f2
https://doi.org/10.1177/10600280221118959
https://doi.org/10.1177/10600280221118959